课题基金 / 基金详情

Investigation of Cancer Predisposition in Heterozygous Carriers of the ATM

Investigation of Cancer Predisposition in Heterozygous Carriers of the ATM
ATM 杂合子携带者癌症易感性调查
批准号:
nhmrc : 241925
负责人:
Prof Martin Lavin
金额:
$54.86万
依托单位:
依托单位国家:
澳大利亚
项目类别:
NHMRC Project Grants
财政年份:
2003
资助国家:
澳大利亚
项目状态:
已结题
起止时间:
2003-01-01 至 2007-12-31

项目摘要

项目成果

Prof Martin Lavin的其他基金

相似基金

相关文献

中文摘要
翻译
患有人类遗传性疾病共济失调-毛细血管扩张症的人容易患癌症,他们的父母和亲属(携带者)也是如此,他们的父母和亲属(携带者)有一个缺陷的基因副本。这是一种多系统疾病,也以神经退化、免疫缺陷、不孕不育和对辐射极度敏感为特征。该项目旨在建立一种这种疾病的小鼠模型,以研究缺陷基因携带者对癌症的易感性。已经在一名乳腺癌患者身上描述了将被引入老鼠体内的特殊突变,并已证明它会干扰ATM蛋白的正常功能。小鼠模型预计将密切反映人类疾病,并将提供机会,监测杂合子携带者的癌症发展。这一模型有望证实在人类中的观察结果,并为了解患癌症的易感性提供资源。该模型还将解决暴露于低剂量辐射和患癌症风险的问题。
英文摘要
Individuals with the human genetic disorder ataxia-telangiectasia are prone to cancer development and so also are their parents and relatives (carriers) who have one defective copy of the gene. This is a multisystem disease that is also characterized by neurodegeneration, immunodeficiency, infertility and extreme sensitivity to radiation. This project is designed to generate a mouse model of this disease to investigate cancer susceptibility in carriers of the defective gene. The specific mutation to be introduced into the mouse has been described in a patient with breast cancer and it has been shown to interfere with the normal function of the ATM protein. The mouse model is expected to reflect closely the human disease and will provide the opportunity to monitor heterozygous carriers for the development of cancer. This model is expected to confirm the observations in humans and provide a resource to understand susceptibility to develop cancer. The model will also address the issue of exposure to low dose radiation and risk of developing cancer.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Role of senataxin protein in meiotic recombination and sex chromosome inactivation
  • 批准号:
    DP130100389
  • 项目类别:
    Discovery Projects
  • 资助金额:
    $25.36万
  • 财政年份:
    2013
  • 负责人:
    Prof Martin Lavin
  • 依托单位:
Research Fellowship
  • 批准号:
    nhmrc : 1020028
  • 项目类别:
    Research Fellowships
  • 资助金额:
    $73.48万
  • 财政年份:
    2012
  • 负责人:
    Prof Martin Lavin
  • 依托单位:
Role of Senataxin in protecting against neurodegeneration
  • 批准号:
    nhmrc : 631407
  • 项目类别:
    NHMRC Project Grants
  • 资助金额:
    $35.99万
  • 财政年份:
    2010
  • 负责人:
    Prof Martin Lavin
  • 依托单位:
Characterisation of the novel mitochondrial protein (CABC1/ADCK3) and its role in protecting against oxidative stress
  • 批准号:
    DP1092466
  • 项目类别:
    Discovery Projects
  • 资助金额:
    $20.85万
  • 财政年份:
    2010
  • 负责人:
    Prof Martin Lavin
  • 依托单位:
国内基金
海外基金
中国北方人群肺癌患者Cancer/Testis抗原表达谱绘制表位鉴定及功能性抗原特异性CTL制备研究
  • 批准号:
    81673007
  • 项目类别:
    面上项目
  • 资助金额:
    54.0万元
  • 批准年份:
    2016
  • 负责人:
    金时
  • 依托单位: